KORU Medical Systems (KRMD)

Repro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.

Company profile

Ticker

KRMD

Exchange

NASDAQ

Website

www.repro-med.com

CEO

Donald B. Pettigrew

Incorporated

New York

Location

New Jersey

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...

Former names

REPRO MED SYSTEMS INC

SEC CIK

0000704440

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

IRS number

133044880

KRMD stock data

1M 1Y 5Y

News

From Benzinga Pro

KORU Medical Systems: Q2 Earnings Insights

3 Aug 22

KORU Medical Systems (NASDAQ:KRMD) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

KORU Medical Systems Q2 EPS $(0.07), Inline, Sales $6.55M Beat $6.29M Estimate

3 Aug 22

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

Earnings Scheduled For August 3, 2022

3 Aug 22

Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday

24 Jun 22

Stocks That Hit 52-Week Lows On Wednesday

15 Jun 22

Press releases

From Benzinga Pro

KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference

4 Aug 22

KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the

KORU Medical Systems Announces 2022 Second Quarter Financial Results

3 Aug 22

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and

KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022

20 Jul 22

Calendar

3 Aug 22

12 Aug 22

31 Dec 22

Financial summary

Financial statements Chart KRMD financial data

Quarter (USD)	Jun 22	Mar 22	Dec 21	Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	18.27M	18.27M	18.27M	18.27M	18.27M	18.27M
Cash burn (monthly)	1.44M	689.41K	1.2M	847.93K	957.75K	514.06K
Cash used (since last report)	2.06M	987.19K	1.72M	1.21M	1.37M	736.09K
Cash remaining	16.21M	17.28M	16.54M	17.05M	16.89M	17.53M
Runway (months of cash)	11.3	25.1	13.7	20.1	17.6	34.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

KRMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Jun 22	Manko Joseph M. Jr.	Common Stock	Grant	Acquire A	Yes	No	0	6,002	0	7,419,649
30 Jun 22	Donna French	Common Stock	Grant	Acquire A	No	No	2.5	6,002	15.01K	23,052
30 Jun 22	Beck James M	Common Stock	Grant	Acquire A	No	No	2.5	6,002	15.01K	73,582
30 Jun 22	Fletcher R John	Common Stock	Grant	Acquire A	No	No	2.5	9,003	22.51K	118,963

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

KRMD institutional ownership history Ownership history

58.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	36	45	-20.0%
Opened positions	4	4	–
Closed positions	13	10	+30.0%
Increased positions	9	16	-43.8%
Reduced positions	12	11	+9.1%

13F shares	Current	Prev Q	Change
Total value	213.05M	254.54M	-16.3%
Total shares	26.26M	37.47M	-29.9%
Total puts	0	11.6K	EXIT
Total calls	0	0
Total put/call ratio	–	Infinity	–

Largest owners	Shares	Value	Change
Horton Capital Partners	10.74M	$37.49M	0.0%
First Light Asset Management	6.1M	$17.45M	+10.6%
Archon Capital Management	2.95M	$8.44M	+3.3%
Vanguard	1.34M	$3.84M	-0.4%
Altium Capital Management	995.5K	$2.85M	0.0%
Albion Financial	990K	$2.83M	-1.0%
Parkman Healthcare Partners	672.46K	$1.92M	+12.5%
272 Capital	520.54K	$1.49M	-0.1%
BLK Blackrock	350.44K	$1M	-0.9%
Geode Capital Management	322.58K	$922K	+2.0%

Largest transactions	Shares	Bought/sold	Change
Horton Capital Management	0	-10.79M	EXIT
First Light Asset Management	6.1M	+585.71K	+10.6%
RY Royal Bank Of Canada	545	-480.56K	-99.9%
Acuitas Investments	0	-273.13K	EXIT
MS Morgan Stanley	5.29K	-169.28K	-97.0%
Adirondack Retirement Specialists	53.88K	-119.37K	-68.9%
Archon Capital Management	2.95M	+93.42K	+3.3%
Parkman Healthcare Partners	672.46K	+74.85K	+12.5%
Royce & Associates	0	-64.4K	EXIT
Renaissance Technologies	0	-43.53K	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbott, accelerated, appointed, appointment, bachelor, Becton, buildout, chain, chattel, Christopher, collateral, Construction, contract, create, created, criteria, degree, designated, Dickinson, difficult, dual, economy, eliminated, elimination, event, experience, experienced, flat, gave, geopolitical, Hillrom, IA, inclusive, inflation, inflationary, iv, joined, Lender, Mahwah, Manuel, milestone, Modification, National, newly, NJ, nominal, open, orderly, organization, paper, past, Pazdan, percent, Pharma, pledge, priority, promised, responsibility, restated, restructuring, Rexam, Senior, serve, served, Sr, technology, tender, travel, treatment, University, Vice, war, Wockhardt

Removed: anniversary, announced, annum, bear, calendar, Chronic, closing, commencement, consecutive, continuity, customary, default, Deficiency, Demyelinating, departure, disease, division, exemption, fewer, financed, fixed, fulfillment, granting, Immune, Inflammatory, installment, KEF, kind, largest, Linda, margin, Master, med, met, monitor, MSA, penalty, periodic, Polyneuropathy, PPLSA, precipitated, prepayment, promissory, registration, replacement, replacing, repro, secure, secured, seeking, strategy, Tharby, type, typical, unpaid

From filing 10-Q 2022 Q2

Financial reports

View all